AHLA to Host AI and Health Law Convener

The American Health Law Association (AHLA) will host a convener on AI and Health Law on March 10, 2020, at the Microsoft Innovation & Policy Center in Washington, DC, bringing together more than a dozen thought leaders including regulators, clinicians, private practitioners, and other leading authorities for an in-depth discussion of AI in health care.

Artificial intelligence is poised to become a transformational force in health care. There are nearly endless opportunities to leverage technology to deploy more precise, efficient, and impactful interventions at exactly the right moment in a patient’s care. Inevitably, health law will have to respond to these changes.

“This is a great opportunity for deep dialogue between regulators, the regulated industry and industry experts about the development and use of AI in health care,” comments Kristen Rosati, AHLA Past President, Member of the Convener Planning Workgroup, and Partner at Coppersmith Brockelman PLC. “The industry will benefit enormously from AI, but there are significant legal and ethical challenges ahead that we need to be proactive about.”

“AI innovation in health care continues to outpace the law,” adds Alaap Shah, Member of the Convener Planning Workgroup and Member at Epstein Becker & Green PC. “AHLA’s efforts to convene a group to address ethical and legal dimensions of AI comes at a critical time to help build awareness about how to navigate these risks.”

Confirmed convener participants include:

• José Arrieta, Chief Information Officer (CIO), HHS Office of the Secretary
• Joseph Ashkouti, Chief Privacy Officer, Change Healthcare
• Daniel Barth-Jones, Assistant Professor of Clinical Epidemiology, Columbia University Mailman School of Public Health
• Elisabeth Belmont, Corporate Counsel, MaineHealth
• Glenn Cohen, James A. Attwood and Leslie Williams Professor of Law, Harvard Law School, Faculty Director, Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics
• Michael Halaas, Deputy Chief Information Officer, Stanford Health Care and School of Medicine
• Elisa Jillson, Federal Trade Commission, Bureau of Consumer Protection, Division of Privacy and Identity Protection
• Nathan Leong, Senior Attorney, Director US Health & Life Sciences, Microsoft
• Bakul Patel, Director, Division of Digital Health, FDA
• Nicholson Price, University of Michigan School of Law
• Jack Resneck Jr., MD Immediate Past Chair, Board of Trustees, American Medical Association
• Suchi Saria, John C. Malone Assistant Professor, Department of Computer Science, Johns Hopkins University
• Ingrid Vasiliu-Feltes, MD, Chief Quality and Innovation Officer, MEDNAX

Although AHLA conveners are closed to the public and press to ensure a full and open dialogue among invited stakeholders, the main perspectives and themes from the discussion will be summarized and consolidated into a white paper that will be distributed to convener attendees, AHLA leaders, members, and the public in early summer 2020.

Additionally, AHLA will expand its current educational offerings in this important subject matter area with a four-part webinar series dedicated to key legal issues for AI in health care:

1. AI and Health Law: Overview—Myth Versus Reality—February 25
2. AI and Health Law: Payment and Coverage Issues—March 31
3. AI and Health Law: Liability Issues and Data Bias—April 28
4. AI and Health Law: Privacy and Security—May 19

The webinar series is free to AHLA members as a benefit of membership. An information Hub will be created on AHLA’s website devoted to AI in health care, to offer a one-stop shop for AI-related resources for AHLA members and the general public.

For general inquiries and press passes for the webinar series, please contact Stefan Bradham. Convener specific questions should be addressed to members of the Convener Planning Workgroup: Kristen Rosati of Coppersmith Brockelman, PLC at [email protected] and Alaap B. Shah of Epstein Becker & Green PC at [email protected].